|
|
 |
|
NSAIDsHealthy Horse Tip – As USEF NSAID Rules Change It’s Time to Go Organic
NSAIDs (non-steroidal anti-inflammatory drugs) may help mask lameness while reducing pain, swelling, and inflammation, but they can also be very harmful to the equine, whether pet or athlete. NSAIDs can contribute to GI ulcers, diarrhea from colitis and colic, which all may trigger bouts of laminitis. Even short term NSAID use has the potential for renal (kidney) and liver toxicity, and may decrease a horse’s health and performance. Research has shown that NSAIDs may also slow down the healing process of soft tissues. This means that the patient using NSAIDs may look normal and not have pain evident, but the tissue is weaker longer and at a higher risk for re-injury during the extended healing period. The USEF now requires an “NSAID Disclosure form” to be filed with the Steward/Technical Delegate if more than one NSAID is used during a competition or in the five days preceding a USEF competition. The use of Bute and Banamine together is currently prohibited. Starting December 1, 2011, the presence of only one NSAID will be allowed! The seven NSAIDs currently allowed with quantitative restrictions are Bute, Banamine, Naproxen, Ketofen, Arquel, Equioxx, and topical Surpass. FEI General Assembly Unanimously Approves 2011 Equine Prohibited Substances List
Taipei, 5 November 2010 – The FEI General Assembly has unanimously accepted the recommendations of the FEI List Group and approved the updated Equine Prohibited Substances List for the 2011 season. National Federation delegates applauded spontaneously at the announcement of the vote. The List was put forward by the FEI List Group following a year of consultation with National Federations and experts, and after the highly successful Congress on the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the equine athlete hosted by the FEI in Lausanne, Switzerland in August. The 2011 List respects horse welfare and ensures a level playing field. The List does not allow the use of NSAIDs in competition. However it was agreed that the FEI should provide a greater level of guidance regarding the detection times for the post-event usage of certain NSAIDs, specifically Phenylbutazone and Flunixin, in commonly used low dosages. As USEF NSAID Rules Change, It’s Time to Go Organic
NSAIDs (non-steroidal anti-inflammatory drugs) may help mask lameness while reducing pain, swelling, and inflammation, but they can also be very harmful to the equine athlete. NSAIDs can contribute to GI ulcers and colic, renal and liver toxicity, and decrease a horse’s health and performance. The USEF now requires a “NSAID Disclosure form” to be filed with the Steward/Technical Delegate if more than one NSAID is used during a competition or in the 5 days preceding a USEF competition. Starting December 1, 2011, the presence of only one NSAID will be allowed! The seven NSAIDs currently allowed with quantitative restrictions are Bute, Banamine, Naproxen, Ketofen, Arquel, Equioxx, and topical Surpass. KAM Animal Services offers FRE Choice Liquid as a safe effective NSAID alternative. FRE Liquid has been used in show and race horses for years with great success and is veterinarian tested and endorsed. It has none of the negative side effects or risks that the above NSAIDs are known for. FEI Congress Hailed as Invaluable Contribution to Debate In-competition Use of NSAIDs Dr Martial Saugy, Professor Tim Greet, Frank Kemperman, Brough Scott and Chris Hodson discussed the public perception of equestrian sports, sponsors and the media perspective on the use of NSAIDs in competition. (Photograph: Patrick Luscher/FEI) 17 August 2010 – The FEI Congress on Non-Steroidal Anti-Inflammatory Drugs (NSAID) Usage and Medication in the Equine Athlete has been hailed as an invaluable contribution to the debate on the in-competition use of NSAIDs. In a ground-breaking approach by the FEI, the Congress brought together the most up-to-date scientific data and non-scientific aspects of NSAID usage for over 200 delegates from 29 countries at the two-day Congress, which wound up at the Olympic Museum in Lausanne, Switzerland today. The second day of the Congress clearly demonstrated that this is a debate that cannot be viewed purely from a scientific perspective and that ethical values and legal issues also have to be taken into account. Following yesterday’s mainly science-based presentations, FEI General Counsel Lisa Lazarus opened this morning’s session by outlining details from nine European countries that prohibit or may prohibit the use of NSAIDs under national law. In light of these legal issues, Ms Lazarus stated that the FEI has two options: either abandon any proposed change in the treatment of NSAIDs, maintaining the status quo that NSAIDs cannot be administered to sport horses during FEI competition anywhere in the world; or permit the use of NSAIDs at appropriate levels as far as the FEI and its members are concerned, but make it clear to all Athletes and participants that the FEI’s rules do not supersede national law, and that anyone participating in the sport in any of the nine countries must note that national laws prohibit, or may prohibit, the use of NSAIDs. Read more> http://www.horsesinthesouth.com/article/article_detail.aspx?id=11901 FEI President Welcomes “Long Overdue” Congress on NSAIDs FEI President HRH Princess Haya gives the opening address at the FEI Congress on NSAID Usage and Medication in the Equine Athlete. (Photograph: Patrick Luscher/FEI) 16 August 2010 – FEI President HRH Princess Haya welcomed the FEI initiative to hold a Congress on Non-Steroidal Anti-Inflammatory Drugs (NSAID) Usage and Medication in the Equine Athlete, declaring it as long overdue and the first real opportunity to bring together all the new science on NSAIDs since the FEI’s 1993 ban on their use in competition. “Knowledge and an understanding of all aspects in the debate on NSAIDs is key to an informed decision,” the FEI President stated in her opening address. “What we all most want from this Congress above all else is to give us, the FEI family, the tools and the confidence to have the wisdom to do what we all so clearly have shown we want to do – that is what is right for our partner, the horse,” she said, emphasising the universal message of the Congress and the paramount principle of the sport, the welfare of the horse. The President was speaking at the first day of the Congress, which is being held in the Olympic Museum in Lausanne, Switzerland. During today’s three sessions, 12 leading research experts outlined the current state of knowledge on NSAIDs to over 200 Congress participants representing 29 nationalities. Congress participants heard that there is a substantial amount of new scientific evidence on the nature of NSAIDs, including improved ways of detecting them, their effect on the body and their side effects, as well as the effect of low levels of intake and combining different NSAIDs. Read more> http://www.horsesinthesouth.com/article/article_detail.aspx?id=11891 Updated Timetable & Feedback Opportunity for FEI Congress on In-competition Use of NSAIDs4 August 2010 – An updated timetable for the FEI global Congress on Non-Steroidal Anti-Inflammatory Drugs (NSAID) Usage and Medication in the Equine Athlete, which will be held at the Olympic Museum in Lausanne, Switzerland on 16 and 17 August 2010 is now available here. All stakeholders who wish to record their views or share relevant information with the FEI on this important debate, including organisers, athletes, sponsors or media, are invited to send an email to nsaidcongress2010@fei.org. All comments will be recorded and the feedback opportunity will remain available until immediately before the FEI General Assembly in November, when the vote on the in-competition use of NSAIDs will take place. Media Contact: Grania Willis Timetable Announced for FEI Congress on In-Competition Use of NSAIDs2 July 2010 – Leading world experts on Non-Steroidal Anti-Inflammatory Drugs (NSAID) research in equestrian sport will be joined by prominent speakers from the non-scientific field at the FEI global Congress on NSAID Usage and Medication in the Equine Athlete which will be held at the Olympic Museum in Lausanne, Switzerland on 16 and 17 August 2010. Roly Owers (GBR), Chief Executive of World Horse Welfare, will talk on ethical and welfare implications of permitting the use of NSAIDs in competition and Dr Lynn Hillyer (GBR), veterinary adviser to the British Horseracing Authority, will address the conference on the topic of why racing authorities have banned NSAIDs in racing. The World Anti-Doping Agency (WADA) perspective on the in-competition use of NSAIDs will be presented by Dr Martial Saugy (SUI), Director of the WADA Laboratory in Lausanne, while the equine veterinary angle will be further boosted by recently confirmed speaker Peter Kallings (SWE), who will talk about the effects of NSAIDs use on equine performance. World Experts to Speak at Global FEI Congress on In-competition Use of NSAIDs4 June 2010 – Leading experts on Non-Steroidal Anti-Inflammatory Drugs (NSAID) research in equestrian sport will address the FEI Congress on NSAID Usage and Medication in the Equine Athlete in Lausanne, Switzerland this summer. Dr Wayne McIlwraith (USA), Professor Pierre-Louis Toutain (FRA) and Professor Ken Hinchcliffe (AUS) will be part of a high-level panel of speakers at the Congress, which will be held at the Olympic Museum in Lausanne, Switzerland on 16/17 August 2010. Dr McIlwraith will speak on the effectiveness of NSAIDs in pain control, Professor Toutain on determining effective levels and Professor Hinchcliffe on the effects NSAIDs may have on equine performance. In order to bring together the various aspects of this important debate, speakers on the non-scientific perspective will also be involved in panel discussions. This will allow for the presentation of important non-scientific aspects, including the legal status in certain countries, and the media and sponsors’ perspective, enabling a full overview of the subject. Use of NSAIDs to Be Put to Vote at 2010 General Assembly
In line with the Bureau’s earlier decision, the present Equine Prohibited List and its accompanying Rules and Veterinary Regulations will remain in effect until 4 April 2010. As of 5 April 2010, the FEI will implement the 20 October Prohibited Substances List, a more detailed version of the present Equine Prohibited List which received no specific objections during the four-week pre-General Assembly consultation period. The new Equine Anti-Doping and Controlled Medication Regulations (EADCMRs) and revised Veterinary Regulations, which both received strong support at the General Assembly, will also be implemented on 5 April 2010. In the interim, the List Group, which will be reviewed to include representatives from additional stakeholders including relevant animal welfare groups, will conduct a full review of the Equine Prohibited Substances List, with all the relevant and necessary research, and will take into account all comments from interest groups received following the 2009 General Assembly vote. In particular, the List Group will be looking at NSAIDs and will further review whether or not the use of these substances in competition, singly and at specifically prescribed levels, is a threat to horse welfare and whether or not these substances, at specific levels, are performance enhancing. Read more> http://www.horsesinthesouth.com/article/article_detail.aspx?id=9341 FEI Delays Implementation of New Prohibited Substances List
The FEI recognizes that a number of issues arise as a result of this policy change, which was voted in by a majority of 53-48 at the meeting in Copenhagen on 19 November. The change in policy will affect National Federations and organizers who must comply with state laws as well as international competition rules. It has implications for the breeding industry and the selection of horses and may impact on all those concerned with animal welfare. It also affects the laboratories involved in the testing procedures. The decision, which reversed the 1993 ban on phenylbutazone, has provoked considerable debate among FEI stakeholders. The FEI acknowledges that these concerns are all legitimate and feels that there is clearly a need for further debate on the issue. The delayed implementation of the new Equine Prohibited Substances List will also allow for supplementary research to be carried out on the use of NSAIDs in the competition horse. Read more> http://www.horsesinthesouth.com/article/article_detail.aspx?id=9052 |
